Adjuvant chemotherapy for completely resected non-small cell lung cancer with TS-1 [S 1] - evaluation of predictive factors for prognosis
Latest Information Update: 15 Sep 2020
Price :
$35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms KOLK-2
- 08 Sep 2020 Status changed from recruiting to completed.
- 27 Mar 2012 Planned End Date changed from 1 Feb 2015 to 1 Oct 2017 as reported by University Hospital Medical Information Network - Japan.
- 27 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.